These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 19133120

  • 1. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.
    Wells V, Mallucci L.
    Breast Cancer Res; 2009; 11(1):R2. PubMed ID: 19133120
    [Abstract] [Full Text] [Related]

  • 2. Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
    Weingaertner IR, Koutnik S, Ammer H.
    PLoS One; 2013; 8(1):e53510. PubMed ID: 23308242
    [Abstract] [Full Text] [Related]

  • 3. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C, Huang L, Gest C, Xi X, Janin A, Soria C, Li H, Lu H.
    J Hematol Oncol; 2012 Jul 11; 5():16. PubMed ID: 22534171
    [Abstract] [Full Text] [Related]

  • 4. Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells.
    Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, Kappler M, Lebigot I, Djelti F, Tourdès A, Gestraud P, Hupé P, Barillot E, Cruzalegui F, Tucker GC, Stern MH, Thiery JP, Hickman JA, Dubois T.
    Breast Cancer Res; 2008 Jul 11; 10(6):R101. PubMed ID: 19055754
    [Abstract] [Full Text] [Related]

  • 5. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL, Sugimoto Y, Liu S, Wang LS, Huang YW, Ye W, Lin YC.
    Anticancer Res; 2009 Aug 11; 29(8):3195-205. PubMed ID: 19661335
    [Abstract] [Full Text] [Related]

  • 6. Killing of Kras-mutant colon cancer cells via Rac-independent actin remodeling by the βGBP cytokine, a physiological PI3K inhibitor therapeutically effective in vivo.
    Mallucci L, Shi DY, Davies D, Jordan P, Nicol A, Lotti L, Mariani-Costantini R, Verginelli F, Wells V, Zicha D.
    Mol Cancer Ther; 2012 Sep 11; 11(9):1884-93. PubMed ID: 22752425
    [Abstract] [Full Text] [Related]

  • 7. Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.
    Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA.
    Int J Cancer; 2010 Jan 15; 126(2):545-62. PubMed ID: 19609946
    [Abstract] [Full Text] [Related]

  • 8. Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of Akt-mediated gene repression.
    Nencioni A, Cea M, Garuti A, Passalacqua M, Raffaghello L, Soncini D, Moran E, Zoppoli G, Pistoia V, Patrone F, Ballestrero A.
    PLoS One; 2010 Feb 02; 5(2):e9024. PubMed ID: 20126311
    [Abstract] [Full Text] [Related]

  • 9. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
    Huang W, Wu QD, Zhang M, Kong YL, Cao PR, Zheng W, Xu JH, Ye M.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):862-71. PubMed ID: 25449780
    [Abstract] [Full Text] [Related]

  • 10. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
    Thapa N, Choi S, Tan X, Wise T, Anderson RA.
    J Biol Chem; 2015 Jul 24; 290(30):18843-54. PubMed ID: 26070568
    [Abstract] [Full Text] [Related]

  • 11. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
    Adya R, Tan BK, Punn A, Chen J, Randeva HS.
    Cardiovasc Res; 2008 May 01; 78(2):356-65. PubMed ID: 18093986
    [Abstract] [Full Text] [Related]

  • 12. ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.
    Pancholi S, Lykkesfeldt AE, Hilmi C, Banerjee S, Leary A, Drury S, Johnston S, Dowsett M, Martin LA.
    Endocr Relat Cancer; 2008 Dec 01; 15(4):985-1002. PubMed ID: 18824559
    [Abstract] [Full Text] [Related]

  • 13. FOXO1A is a target for HER2-overexpressing breast tumors.
    Wu Y, Shang X, Sarkissyan M, Slamon D, Vadgama JV.
    Cancer Res; 2010 Jul 01; 70(13):5475-85. PubMed ID: 20551062
    [Abstract] [Full Text] [Related]

  • 14. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Way TD, Kao MC, Lin JK.
    J Biol Chem; 2004 Feb 06; 279(6):4479-89. PubMed ID: 14602723
    [Abstract] [Full Text] [Related]

  • 15. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
    Liu L, Zhao X, Pierre SV, Askari A.
    Am J Physiol Cell Physiol; 2007 Nov 06; 293(5):C1489-97. PubMed ID: 17728397
    [Abstract] [Full Text] [Related]

  • 16. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 06; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 17. Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells.
    Serova M, Ghoul A, Benhadji KA, Faivre S, Le Tourneau C, Cvitkovic E, Lokiec F, Lord J, Ogbourne SM, Calvo F, Raymond E.
    Mol Cancer Ther; 2008 Apr 06; 7(4):915-22. PubMed ID: 18413805
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
    Menendez JA, Mehmi I, Verma VA, Teng PK, Lupu R.
    Mol Carcinog; 2004 Nov 06; 41(3):164-78. PubMed ID: 15390078
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-related receptor alpha1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway.
    Ariazi EA, Kraus RJ, Farrell ML, Jordan VC, Mertz JE.
    Mol Cancer Res; 2007 Jan 06; 5(1):71-85. PubMed ID: 17259347
    [Abstract] [Full Text] [Related]

  • 20. Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways.
    Siddiqa A, Long LM, Li L, Marciniak RA, Kazhdan I.
    BMC Cancer; 2008 May 02; 8():129. PubMed ID: 18454859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.